Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
This article has been cited by
1Prognostic Role of PD-L1 Expression in Invasive Breast Cancer: A Systematic Review and Meta-Analysis
Magno Belém Cirqueira,Carolina Rodrigues Mendonça,Matias Noll,Leonardo Ribeiro Soares,Maria Auxiliadora de Paula Carneiro Cysneiros,Regis Resende Paulinelli,Marise Amaral Rebouças Moreira,Ruffo Freitas-Junior
2PD-L1 expression in breast cancer: expression in subtypes and prognostic significance: a systematic review
Elisabeth Specht Stovgaard,Anne Dyhl-Polk,Anne Roslind,Eva Balslev,Dorte Nielsen
Breast Cancer Research and Treatment.2019;174(3)571
3Prognostic and clinicopathological value of PD-L1 expression in primary breast cancer: a meta-analysis
Wenfa Huang,Ran Ran,Bin Shao,Huiping Li
Breast Cancer Research and Treatment.2019;178(1)17
4Anticancer Effects of Thymoquinone through the Antioxidant Activity, Upregulation of Nrf2, and Downregulation of PD-L1 in Triple-Negative Breast Cancer Cells
Getinet M. Adinew,Samia S. Messeha,Equar Taka,Ramesh B. Badisa,Karam F. A. Soliman
5Pilot Study: Immune Checkpoints Polymorphisms in Greek Primary Breast Cancer Patients
Nyanbol Kuol,Xu Yan,Vanessa Barriga,Jimsheena Karakkat,Stamatis Vassilaros,Ioannis Fyssas,Anastasios Tsimpanis,Sarah Fraser,Kulmira Nurgali,Vasso Apostolopoulos
6The expression of programmed death-ligand 1 and its association with histopathological grade, stage of disease, and occurrence of metastasis in breast cancer
Agung Sindu Pranoto,Haryasena Haryasena,Prihantono Prihantono,Septiman Rahman,Daniel Sampepajung,Indra Indra,Salman Ardy Syamsu,Elridho Sampepajung,Berti Julian Nelwan,Muhammad Faruk,Andi Nilawati Usman
Breast Disease.2021;40(s1)S71
7Determining Factors in the Therapeutic Success of Checkpoint Immunotherapies against PD-L1 in Breast Cancer: A Focus on Epithelial-Mesenchymal Transition Activation
Mariana Segovia-Mendoza,Susana Romero-Garcia,Cristina Lemini,Heriberto Prado-Garcia,francesca bianchi
Journal of Immunology Research.2021;2021(s1)1
8NPM1 upregulates the transcription of PD-L1 and suppresses T cell activity in triple-negative breast cancer
Ge Qin,Xin Wang,Shubiao Ye,Yizhuo Li,Miao Chen,Shusen Wang,Tao Qin,Changlin Zhang,Yixin Li,Qian Long,Huabin Hu,Dingbo Shi,Jiaping Li,Kai Zhang,Qinglian Zhai,Yanlai Tang,Tiebang Kang,Ping Lan,Fangyun Xie,Jianjun Lu,Wuguo Deng
Nature Communications.2020;11(1)1
9Programmed Cell Death Ligand 1 in Breast Cancer: Technical Aspects, Prognostic Implications, and Predictive Value
Federica Miglietta,Gaia Griguolo,Valentina Guarneri,Maria Vittoria Dieci
The Oncologist.2019;24(11)e1055
10Differences of the Immune Phenotype of Breast Cancer Cells after Ex Vivo Hyperthermia by Warm-Water or Microwave Radiation in a Closed-Loop System Alone or in Combination with Radiotherapy
Michael Hader,Deniz Pinar Savcigil,Andreas Rosin,Philipp Ponfick,Stephan Gekle,Martin Wadepohl,Sander Bekeschus,Rainer Fietkau,Benjamin Frey,Eberhard Schlücker,Udo S. Gaipl
11Clinicopathological and prognostic significance of programmed cell death ligand 1 expression in patients diagnosed with breast cancer: meta-analysis
M G Davey,É J Ryan,M S Davey,A J Lowery,N Miller,M J Kerin
British Journal of Surgery.2021;108(6)622
12Resistance mechanisms to programmed cell death protein 1 and programmed death ligand 1 inhibitors
Parmida Sadat Pezeshki,Pouya Mahdavi Sharif,Nima Rezaei
Expert Opinion on Biological Therapy.2021;21(12)1575
13In Vitro Examinations of Cell Death Induction and the Immune Phenotype of Cancer Cells Following Radiative-Based Hyperthermia with 915 MHz in Combination with Radiotherapy
Michael Hader,Simon Streit,Andreas Rosin,Thorsten Gerdes,Martin Wadepohl,Sander Bekeschus,Rainer Fietkau,Benjamin Frey,Eberhard Schlücker,Stephan Gekle,Udo S. Gaipl
14Overexpression of an Immune Checkpoint (CD155) in Breast Cancer Associated with Prognostic Significance and Exhausted Tumor-Infiltrating Lymphocytes: A Cohort Study
Yu-Chen Li,Quan Zhou,Qing-Kun Song,Rui-Bin Wang,Shuzhen Lyu,Xiudong Guan,Yan-Jie Zhao,Jiang-Ping Wu
Journal of Immunology Research.2020;2020(6)1

Subscribe this journal
Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal